Key Financial Data Of Reporting Company

Oncolys BioPharma Inc. - Filing #7712871

Concept As at
2018-09-30
2018-07-01 to
2018-09-30
2018-01-01 to
2018-09-30
As at
2017-12-31
2017-01-01 to
2017-12-31
As at
2017-09-30
2017-01-01 to
2017-09-30
2017-07-01 to
2017-09-30
Key financial data of reporting company
Business results of reporting company
Net sales
118,422,000 JPY
229,139,000 JPY
29,027,000 JPY
Ordinary profit (loss)
-899,150,000 JPY
-1,087,185,000 JPY
-776,782,000 JPY
Profit (loss)
-901,951,000 JPY
-1,090,703,000 JPY
-779,361,000 JPY
Equity in earnings (losses) of affiliates if equity method is applied
JPY
JPY
JPY
Share capital
6,203,996,000 JPY
5,802,444,000 JPY
5,764,213,000 JPY
Total number of issued shares
12,564,000 xbrli:shares
11,086,000 xbrli:shares
10,972,800 xbrli:shares
Net assets
2,856,896,000 JPY
2,931,893,000 JPY
3,165,334,000 JPY
Total assets
3,345,203,000 JPY
3,526,222,000 JPY
3,775,634,000 JPY
Dividend paid per share
Basic earnings (loss) per share
-21.81
-79.31
-106.23
-77.81
-24.18
Diluted earnings per share
Equity-to-asset ratio
0.850 xbrli:pure
0.829 xbrli:pure
0.835 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.